| STD Update 2012: Epidemiology and Clinical Care |  | 
|  |
| Stay Up-To-Date on STDs in San Francisco |  | 
|  |
| Reportable STD Rates, San Francisco 2007-2011 |  | 
|  |
| STDs among MSM in San Francisco, 2011 |  | 
|  |
| Early Syphilis Rates (per 100,000 population), San Francisco 2007-2011 |  | 
|  |
| Demographics of Early Syphilis STD Update 2012 |  | 
|  |
| Age of Early Syphilis STD Update 2012 |  | 
|  |
| Reporting Provider of Early Syphilis STD Update 2012 |  | 
|  |
| Behavioral Risks of Interviewed Early Syphilis STD Update 2012 |  | 
|  |
| STDs among Adolescents in San Francisco, 2011 (1) |  | 
|  |
| Chlamydia Rates (per 100,000 population), San Francisco 2007-2011 |  | 
|  |
| Syphilis Staging Flowchart |  | 
|  |
| To LP or Not to LP, That is the Question |  | 
|  |
| What Is the Clinical Significance of Persistent Stable Titers (Serofast)? |  | 
|  |
| Tests of Choice for Gonorrhea and Chlamydia |  | 
|  |
| What If Non-genital STDs Were Ignored? |  | 
|  |
| Proportion of asymptomatic rectal and urethral chlamydial and gonococcal infection among MSM - San Francisco, 2003 |  | 
|  |
| History of Antibiotics for NG |  | 
|  |
| Penicillinase-Producing N. Gonorrhoeae (1970s - 1980s) and the Spread of Ciprofloxacin Resistance (1990s - 2000s) |  | 
|  |
| The Gonococcal Isolate Surveillance Project (GISP) |  | 
|  |
| GISP Sites and Regional Laboratories - United States, 2000-2010 |  | 
|  |
| The Emerging Threat of Untreatable Gonococcal Infection |  | 
|  |
| Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010 |  | 
|  |
| Current Recommended Gonorrhea Treatment |  | 
|  |
| Alternative Gonorrhea Treatment for Uncomplicated Urogenital GC |  | 
|  |
| What if I Suspect Gonorrhea Treatment failure? |  | 
|  |
| What about Patients with Penicillin or Cephalosporin Allergies? |  | 
|  |
| SFDPH Response to Gonorrhea in San Francisco |  | 
|  |
| Reported Gonorrhea by Diagnosing Provider, 2011 |  | 
|  |
| Reported Gonorrhea Treatment SF July 1 2011-June 30 2012 (n= 3071) |  | 
|  |
| Follow-Up for STD Clinic Patients at Risk for Treatment Failure |  | 
|  |
| CA GISP SF Results Jan 2012-Sept 2012 |  | 
|  |
| Rapid, Molecular Methods to Assess Susceptibility? |  | 
|  |
| Since We Still Need Culture, How to Get it to the Lab? |  | 
|  |
| When to Retest for TOC with NAAT? |  | 
|  |
| When to Retest for TOC with NAAT? |  | 
|  |
| Other Alternative Treatment? |  | 
|  |
|
 |